Hematology Transfusion and Cell Therapy

Scope & Guideline

Pioneering insights in hematology and transfusion care.

Introduction

Welcome to the Hematology Transfusion and Cell Therapy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Hematology Transfusion and Cell Therapy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2531-1379
PublisherELSEVIER
Support Open AccessYes
CountryBrazil
TypeJournal
Convergefrom 2018 to 2024
AbbreviationHEMATOL TRANSF CELL / Hematol. Transf. Cell Ther.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hematology Transfusion and Cell Therapy' focuses on advancing the understanding and treatment of hematological disorders and transfusion medicine. It aims to publish high-quality research that contributes to the clinical practice and scientific knowledge in these fields.
  1. Hematological Disorders:
    The journal covers a wide range of hematological conditions, including leukemias, lymphomas, myelomas, and other blood disorders, emphasizing both clinical and laboratory research.
  2. Transfusion Medicine:
    Research related to blood transfusion practices, safety, and efficacy, including studies on blood components, transfusion reactions, and management protocols.
  3. Cell Therapy and Stem Cell Transplantation:
    Focus on advancements in cell therapies, including hematopoietic stem cell transplantation techniques, outcomes, and challenges, particularly in resource-limited settings.
  4. Infectious Complications in Hematology:
    Exploration of infectious risks associated with hematological diseases and treatments, particularly in the context of COVID-19 and other emerging infections.
  5. Genetic and Molecular Studies:
    Research investigating genetic factors influencing hematological diseases, including molecular diagnostics, biomarkers for disease prognosis, and treatment responses.
  6. Patient Management and Quality of Life:
    Studies addressing patient care strategies, including management of symptoms, side effects of treatments, and overall patient quality of life in hematological settings.
Recent publications indicate emerging themes and trends that reflect the evolving landscape of hematology, transfusion medicine, and cell therapy. These trends highlight the journal's responsiveness to current challenges and advancements in the field.
  1. Impact of COVID-19 on Hematology:
    A significant increase in research addressing the effects of COVID-19 on patients with hematological conditions, including complications, treatment adaptations, and vaccination responses.
  2. Personalized Medicine and Targeted Therapies:
    Growing emphasis on studies exploring personalized treatment approaches in hematology, particularly the use of genetic markers for tailoring therapies.
  3. Patient Blood Management Strategies:
    Emerging focus on optimizing blood use in clinical settings, including protocols for minimizing transfusions and improving patient outcomes.
  4. Innovations in Cell Therapy:
    Increased interest in novel cell therapies, including CAR-T cell therapy and other advanced therapeutic modalities targeting hematological malignancies.
  5. Health Equity and Access to Care:
    Research highlighting disparities in healthcare access and outcomes for hematology patients, particularly in low- and middle-income countries.
  6. Quality of Life Assessments:
    Growing trend towards evaluating the quality of life and psychosocial impacts of hematological diseases and treatments, reflecting a holistic approach to patient care.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in publication frequency or emphasis over recent years. This may reflect shifts in research focus or advancements in other areas.
  1. Traditional Hematology Techniques:
    There is a noticeable decrease in studies focusing solely on traditional hematological laboratory techniques, as advancements in molecular and genetic diagnostics gain prominence.
  2. Basic Science Research:
    Research that does not directly translate to clinical application is becoming less frequent, as the journal emphasizes studies with immediate clinical relevance.
  3. Historical Perspectives on Hematology:
    Papers focusing on historical analyses or reviews of past practices in hematology are becoming less common, reflecting a shift towards contemporary issues and innovations.

Similar Journals

BRITISH JOURNAL OF HAEMATOLOGY

Advancing the Frontiers of Hematology Research
Publisher: WILEYISSN: 0007-1048Frequency: 23 issues/year

British Journal of Haematology, published by Wiley, is a leading journal in the field of hematology, with an impressive impact factor reflecting its significance in the medical research community. Established in 1955, the journal has consistently contributed to advancing knowledge in hematology, currently holding a prestigious Q1 ranking in the Scopus category of Hematology, placing it in the top 18% of the field. The journal encompasses a broad range of topics including clinical and laboratory aspects of blood disorders and hematological malignancies, making it an essential resource for hematologists, researchers, and healthcare professionals. With its commitment to publishing top-tier research and clinical studies, the British Journal of Haematology plays a critical role in shaping treatment approaches and improving patient outcomes worldwide. Please note that this journal does not offer Open Access options, ensuring that published content is rigorously curated for quality and relevance.

TRANSFUSION MEDICINE REVIEWS

Advancing the frontiers of transfusion medicine.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0887-7963Frequency: 4 issues/year

TRANSFUSION MEDICINE REVIEWS is a prestigious journal dedicated to the advanced study of transfusion medicine and its related fields, published by W B SAUNDERS CO-ELSEVIER INC. With an outstanding reputation, it boasts an impressive impact factor and consistently ranks in the top quartile (Q1) across multiple categories, including Biochemistry (Medical), Clinical Biochemistry, and Hematology. Researchers will find valuable insights through its extensive coverage of pertinent topics, with a focus on the integration of clinical practices and laboratory science. While the journal does not currently offer open access, its content remains accessible through various institutional subscriptions, ensuring that vital information is available to the global scientific community. With a continuous publication history from 1987 to 2024, TRANSFUSION MEDICINE REVIEWS serves as a vital resource for academics, healthcare professionals, and students who seek to stay abreast of the latest research findings and clinical practices in transfusion medicine.

Indian Journal of Hematology and Blood Transfusion

Empowering Healthcare Through Cutting-edge Hematology Research
Publisher: SPRINGER INDIAISSN: 0971-4502Frequency: 4 issues/year

Indian Journal of Hematology and Blood Transfusion, published by SPRINGER INDIA, serves as a leading platform for disseminating original research, reviews, and case studies in the field of hematology. With an ISSN of 0971-4502 and E-ISSN 0974-0449, this journal has been instrumental in advancing knowledge from 2000 to 2024, providing insights into critical issues surrounding blood disorders and transfusion practices. Currently ranked in the Q3 category for Hematology for 2023, it reflects a commitment to high-quality scientific content amidst a competitive landscape where it ranks 97/137 in Scopus for Medicine - Hematology, placing it in the 29th percentile of its peers. The journal primarily addresses a diverse readership, including researchers, healthcare professionals, and students, aiming to foster innovation and collaboration within the field. Although it operates under a subscription model, access options for individual articles and institutional subscriptions ensure that valuable research is disseminated widely to enhance medical practice and education in hematology.

GEMATOLOGIYA I TRANSFUZIOLOGIYA

Elevating Standards in Hematology Research
Publisher: MINISTERSTVO ZDRAVOOKHRANENIYAISSN: 0234-5730Frequency: 4 issues/year

GEMATOLOGIYA I TRANSFUZIOLOGIYA is an esteemed journal published by the MINISTERSTVO ZDRAVOOKHRANENIYA in the Russian Federation, focusing on the vital fields of hematology and transfusion medicine. With a rich history dating back to its inception in 1983, the journal plays a significant role in disseminating critical research and advancements in these areas, particularly relevant given the evolving landscape of medical science. As a recognized publication, it is indexed in Scopus and holds a Q4 category ranking in Hematology for 2023, reflecting its niche but important contributions to the field. Researchers, healthcare professionals, and students can look forward to a variety of peer-reviewed articles that not only address contemporary issues but also pave the way for innovative practices in hematology. Although it does not currently offer open access, the journal remains a valuable resource for those seeking to stay informed about the latest findings and developments.

Anemia

Unlocking the mysteries of blood disorders, one study at a time.
Publisher: HINDAWI LTDISSN: 2090-1267Frequency: 1 issue/year

Anemia is a distinguished open-access journal published by HINDAWI LTD, focusing on the intricate and vital field of hematology and related disciplines. Since its inception in 2010, this journal has been dedicated to advancing our understanding of blood disorders, with a particular emphasis on anemia, through the dissemination of high-quality research that is freely accessible to a global audience. The journal's evolving scope from its founding through 2024 embodies its commitment to include the latest breakthroughs and methodologies in cell biology and hematological research. With its presence in prestigious databases and a tiered ranking that places it in the Q3 category in Hematology and Q4 in Cell Biology as of 2023, Anemia serves as an invaluable resource for researchers, clinicians, and students alike. The journal is indexed with a respectable position in Scopus, ranking 52 out of 137 in Hematology, highlighting its growing influence in the medical and scientific communities. With continued emphasis on open access, Anemia not only fosters collaborative research but also ensures that crucial findings reach those who need them most, enhancing educational outcomes and clinical practices worldwide.

Journal of Hematology

Advancing the Frontiers of Blood Science
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

TRANSFUSION

Advancing the Science of Blood and Beyond
Publisher: WILEYISSN: 0041-1132Frequency: 12 issues/year

TRANSFUSION is a prestigious peer-reviewed journal published by WILEY, dedicated to advancing the field of hematology and transfusion medicine. With an ISSN of 0041-1132 and an E-ISSN of 1537-2995, this journal serves as a vital resource for researchers and professionals alike, delivering high-quality studies and reviews that impact clinical practice and blood management strategies. The journal enjoys a strong reputation, evidenced by its impressive Q1 ranking in hematology and Q2 in both immunology and allergy as of 2023. Covering foundational aspects from 1958 to 2024, TRANSFUSION not only provides valuable insights but also fosters collaboration and innovation in understanding the complexities of blood donation, transfusion practices, and immunological responses. With its significant contributions to the scientific community, this journal is essential for those seeking to stay at the forefront of research and advancements in transfusion science.

Egyptian Journal of Haematology

Empowering Hematologists with Cutting-Edge Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

Hematology-American Society of Hematology Education Program

Navigating the Future of Hematology Together
Publisher: AMER SOC HEMATOLOGYISSN: 1520-4391Frequency: 1 issue/year

Hematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.

TRANSFUSION AND APHERESIS SCIENCE

Transforming Transfusion Practices with Cutting-edge Research
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1473-0502Frequency: 6 issues/year

TRANSFUSION AND APHERESIS SCIENCE, published by Pergamon-Elsevier Science Ltd, serves as a pivotal platform for researchers and practitioners in the fields of hematology, transfusion medicine, and apheresis. With an ISSN of 1473-0502 and an E-ISSN of 1878-1683, this peer-reviewed journal boasts a respectable Q3 ranking in the Hematology category as of 2023, positioning it within the 45th percentile among its counterparts. Operating from the United Kingdom, it provides comprehensive insights into the latest advancements and methodologies in transfusion practices and apheresis technology, crucial for enhancing patient care and therapeutic strategies. The journal's scope, covering key developments from 1996 to 2024, allows for a deep exploration of historical and emerging trends within the discipline. Moreover, its open access options facilitate widespread dissemination of research findings, fostering collaboration and innovation in the scientific community. For those dedicated to advancing knowledge in hematology, TRANSFUSION AND APHERESIS SCIENCE represents an essential resource, bridging theory and practice in this vital area of healthcare.